Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 2, 2009Biology of Blood and Marrow TransplantationOpen Access

Defining the Intensity of Conditioning Regimens: Working Definitions

View Full Paper
Ask AI
Bookmark
Share

Authors

Andrea BacigalupoAndrea BacigalupoUniversité Claude Bernard Lyon 1KBKaren K. BallenUniversity of Virginia Health SystemDRDoug RizzoMedical College of Wisconsin

Discussion

Loading...

Member takes

Implication

Consensus report demonstrates standardized conditioning regimen categories in stem cell transplantation, highlighting cross-study comparability.

Key Points

  • To establish uniform working definitions for categorizing the intensity of conditioning regimens utilized prior to hematopoietic stem cell transplantation.
  • Stratified conditioning regimens into three distinct intensity classes based on duration of cytopenia and the requirement for stem cell support.
  • Categorized commonly used clinical conditioning protocols according to specific agents, dosages, and combination regimens.
  • Defined three consensus categories: myeloablative regimens that cause irreversible cytopenia requiring mandatory stem cell rescue, nonmyeloablative regimens causing minimal cytopenia manageable without rescue, and intermediate reduced-intensity conditioning.
  • Assigned standard chemotherapy and radiation regimens to these three categories to enable consistent comparisons across clinical trials and transplant registries.

Cite This Study

Bacigalupo et al. (2009) studied this question.

synapsesocial.com/papers/69d8323f8c03fbaff8bedf5ehttps://doi.org/10.1016/j.bbmt.2009.07.004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases1998 · 1,793 citations
  2. 2High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy1990 · 99 citations
  3. 3Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long‐term follow‐up2005 · 111 citations